GD pedigree | HT pedigree | AITD pedigrees | ||||
---|---|---|---|---|---|---|
GD patients | Controls | HT patients | Controls | AITD patients | Controls | |
Gender (M/F) | 45/156 (1:3.47) | 136/141 (1:1.04) | 8/21 (1/2.62) | 18/28 (1:1.56) | 54/176 (1:3.25) | 153/170 (1:1.11) |
Age (year) | 43.72 ± 14.31 | 48.95 ± 16.98 | 42.45 ± 19.85 | 47.55 ± 16.75 | 43.60 ± 15.17 | 48.40 ± 17.21 |
TSH (mIU/L) | 0.10 (0.06-1.83) | 1.26 (0.79-2.06) | 2.04 (0.23-9.06) | 2.45 (1.45-3.33) | 0.23 (0.01-2.32) | 1.37 (0.83-2.30) |
FT4 (pmol/L) | 25.81 ± 18.55 | 16.64 ± 3.07 | 18.79 ± 9.87 | 16.50 ± 2.01 | 24.91 ± 17.82 | 16.62 ± 2.94 |
FT3 (pmol/L) | 7.58 ± 6.72 | 4.17 ± 0.89 | 4.71 ± 1.89 | 4.38 ± 0.97 | 7.21 ± 6.39 | 4.20 ± 0.90 |
TPOAb (IU/ml) | 368.50 (46.85-1000) | 10.10 (10.00-29.20) | 1000.00 (458.75-1000.00) | 10.60 (10.00-158.50) | 503.50 (53.13-1000.00) | 10.10 (10.00-33.35) |
TgAb (IU/ml) | 59.95 (20.00-460.00) | 20.00 (20.00-94.70) | 80.60 (31.18-3000.00) | 20.00 (20.00-45.70) | 59.95 (20.00-519.50) | 20.00 (20.00-20.00) |